THE USE OF RISK OF OVARIAN MALIGNANCY ALGORITHM (ROMA) AS A PREDICTOR OF EPITHELIAL OVARIAN CANCER IN WOMEN WITH ADNEXAL MAS

Authors

  • Dr. Sushma Rachel S, Dr. Nagarathna Gopala, Dr. Rohanchandra R Gatty

Keywords:

Ovarian cancer; ROMA; CA125; HE4; Tumor markers.

Abstract

Ovarian cancer is the most common gynecological cancer associated with increasedmortality due to delay in diagnosis. Most of the ovarian cancers are diagnosed at advanced stages and are associated with poorer prognosis and a lower survival rate. Early diagnosis is an important factor inimproving the survival rate.

References

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA: a cancer journal for clinicians. 2008 Mar;58(2):71-96.

Moorman PG, Calingaert B, Palmieri RT, Iversen ES, Bentley RC, Halabi S, Berchuck A, Schildkraut JM. Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women. American journal of epidemiology. 2008 Feb 25;167(9):1059-69.

Downloads

Published

2025-10-17

How to Cite

Dr. Sushma Rachel S, Dr. Nagarathna Gopala, Dr. Rohanchandra R Gatty. (2025). THE USE OF RISK OF OVARIAN MALIGNANCY ALGORITHM (ROMA) AS A PREDICTOR OF EPITHELIAL OVARIAN CANCER IN WOMEN WITH ADNEXAL MAS. International Journal of Pharmacy Research & Technology (IJPRT), 15(2), 2500–2512. Retrieved from https://www.ijprt.org/index.php/pub/article/view/1081

Issue

Section

Research Article

Most read articles by the same author(s)